113 related articles for article (PubMed ID: 33045131)
41. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
42. MiR-940 inhibits the progression of NSCLC by targeting FAM83F.
Gu GM; Zhan YY; Abuduwaili K; Wang XL; Li XQ; Zhu HG; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5964-5971. PubMed ID: 30280778
[TBL] [Abstract][Full Text] [Related]
43. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
[TBL] [Abstract][Full Text] [Related]
44. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
Yang W; Zhou C; Luo M; Shi X; Li Y; Sun Z; Zhou F; Chen Z; He J
Oncotarget; 2016 Mar; 7(13):16703-15. PubMed ID: 26934648
[TBL] [Abstract][Full Text] [Related]
45. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.
Gao N; Wang FX; Wang G; Zhao QS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1693-1699. PubMed ID: 29630114
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524
[TBL] [Abstract][Full Text] [Related]
47. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
[TBL] [Abstract][Full Text] [Related]
48. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
49. The Role of Neurotrophin-4/Forkhead Box L1 in the Development of Nonsmall-Cell Lung Cancer.
Mu L; Zhao H; Zhang Y; Xiao C
Contrast Media Mol Imaging; 2022; 2022():9078012. PubMed ID: 36034210
[TBL] [Abstract][Full Text] [Related]
50. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
Li Q; Wu X; Guo L; Shi J; Li J
FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474
[TBL] [Abstract][Full Text] [Related]
52. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
53. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met.
Luo W; Huang B; Li Z; Li H; Sun L; Zhang Q; Qiu X; Wang E
PLoS One; 2013; 8(5):e64759. PubMed ID: 23734217
[TBL] [Abstract][Full Text] [Related]
55. Altered expression of microRNA-365 is related to the occurrence and development of non-small-cell lung cancer by inhibiting TRIM25 expression.
Han Q; Cheng P; Yang H; Liang H; Lin F
J Cell Physiol; 2019 Dec; 234(12):22321-22330. PubMed ID: 31099423
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
57. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
58. Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer.
Qi Y; Zha W; Zhang W
J BUON; 2019; 24(2):599-607. PubMed ID: 31128012
[TBL] [Abstract][Full Text] [Related]
59. MiR-378 promotes the cell proliferation of non-small cell lung cancer by inhibiting FOXG1.
Ji KX; Cui F; Qu D; Sun RY; Sun P; Chen FY; Wang SL; Sun HS
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1011-1019. PubMed ID: 29509249
[TBL] [Abstract][Full Text] [Related]
60. MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer.
Li X; Chen SH; Zeng JW
Med Princ Pract; 2020; 29(1):80-89. PubMed ID: 31473750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
